Moderna starts tests with mRNA vaccine against influenza
The vaccine mRNA-1010 is the company’s first seasonal flu vaccine candidate to be tested in a clinical trial, according to Moderna. The first test person received the first dose, and around 180 healthy adults are being recruited for further tests. The company has other flu mRNA vaccines in the pipeline. “Moderna’s vision is to develop … Read more